Nortetrazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401535This classification denotes a benzodiazepine with the molecular formula C15H15ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PWL441R6EQ, chemically known as 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as nortetrazepam, which bears US NIH Compound Identifier 166581. European Medicines Agency schedules Nortetrazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09379MIG. The term NORTETRAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). NORTETRAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nortetrazepam under HS 29339940 and SITC 51577. As of Q4 2014, NORTETRAZEPAM remains the US FDA Preferred Term for this commodity. Nortetrazepam bears US NLM identifiers UMLS ID C2698499 and NCI Concept Code C76537. SMILES: CLC1CC2C(=NCC(=O)NC2CC1)C1=CCCCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.